Literature DB >> 9637581

Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset.

P Nishanian1, J M Taylor, B Manna, N Aziz, S Grosser, J V Giorgi, R Detels, J L Fahey.   

Abstract

The trajectories of change in CD4+ and CD8+ lymphocytes and serum neopterin and beta2-microglobulin (beta2M) levels were determined in 158 HIV-seropositive individuals during 5.5 years before a clinical AIDS diagnosis. Each patient was evaluated separately using a two-piece regression model with seven possible change points to identify any adverse change (inflection point) in the slopes of each immunologic marker of HIV infection. Two categories of subjects were distinguished for each marker--those with statistically significant inflection points and those who demonstrated a steady progression of changes to AIDS. Fifty-nine percent had an inflection point for CD4+ T cells. The frequency of inflection points for CD8+ was 49%, for serum neopterin -48% and for beta2M -38%. Inflection points were found over a 4-year span. Three distinctive categories of inflection points were observed on the basis of their independent occurrence: one was in CD4+ T cells, another in CD8+ T cells, and a third in the serum markers of immune activation. The inflection point for CD4+ usually occurred prior to those for CD8+ T cells (p=.0002). The HIV-positive persons with inflection points were diagnosed with AIDS when immunologic parameters were significantly more abnormal than in those with steady progression (p < .0003). Thus, these two groups differed in the course of immune changes and in the levels of immune abnormalities associated with the occurrence of clinical AIDS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637581     DOI: 10.1097/00042560-199806010-00008

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  6 in total

1.  Comparing the Diagnostics Accuracy of CD4+ T-Lymphocyte Count and Percent as a Surrogate Markers of Pediatric HIV Disease.

Authors:  Musie Ghebremichael; Haben Michael; Jack Tubbs; Elijah Paintsil
Journal:  J Math Stat       Date:  2019-04-03

Review 2.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.

Authors:  N Aziz; P Nishanian; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

4.  Frequent Episodes of Detectable Viremia in HIV Treatment-Experienced Children is Associated with a Decline in CD4+ T-cells Over Time.

Authors:  Elijah Paintsil; Ryan Martin; Ariel Goldenthal; Shreya Bhandari; Warren Andiman; Musie Ghebremichael
Journal:  J AIDS Clin Res       Date:  2016-04-14

5.  Monitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two Epidemics.

Authors:  Elijah Paintsil
Journal:  AIDS Res Treat       Date:  2010-12-02

6.  Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana.

Authors:  Lorna Renner; Meghan Prin; Fang-Yong Li; Bamenla Goka; Veronika Northrup; Elijah Paintsil
Journal:  AIDS Res Treat       Date:  2011-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.